Login

Healthcare

00:00:00
Neovasc uses conference to announce positive interim clinical data from Neovasc Reducer use - Bill Little, COO, Neovasc Inc
00:00:00
Miguel Sieler, CEO, Neovacs
00:00:00
US companies set the benchmark for Motif Bio - Graham Lumsden, chief executive of Motif Bio PLC
00:00:00
Eric Poma, CEO of Molecular Templates
00:00:00
Anna Ljung, CEO, Moberg Pharma AB (publ)
00:00:00
CEO Anna Ljung presents Moberg Pharma - Anna Ljung, CEO, Moberg Pharma AB (publ)
00:00:00
Moberg Pharma | Interview - Anna Ljung, CEO, Moberg Pharma AB (publ)
00:00:00
MicroBix (MBX.T) CEO, Cameron L. Groome, talks antigens
00:00:00
Micro-X (ASX:MX1): Peter Rowland, Managing Director, Micro-X Ltd
00:00:00
Medlab Clinical talks upcoming Phase III NanaBis trial and NanoCelle partnering opportunities -Dr Sean Hall, CEO, Medlab Clinical Ltd
00:00:00
Medivir - ABGSC Life Summit May 18 2022 - Jens Lindberg, CEO, Medivir
00:00:00
Medivir presentation - Jens Lindberg, CEO, Medivir
00:00:00
Interviews Jens Lindberg, CEO Medivir at the Swiss Nordic Bio conference in Zürich, Switzerland - Jens Lindberg, CEO, Medivir
00:00:00
Global Health Leadership in the Private Sector - a conversation with Medistim CEO Kari E. Krogstad - Kari E. Krogstad, CEO, Medistim
00:00:00
Mr. Peter Crosby, President and CEO of Mainstay Medical
00:00:00
Medicure, Inc MCUJF CEO Albert Friesen on 2020 Results - Albert D. Friesen, PhD. Chief Executive Officer and Chairman of the Board, Medicure Inc

© 2026 Nehu